Abstract:Abstract Background In tauopathies such as Alzheimer’s disease (AD), aberrant phosphorylation causes the dissociation of tau protein from microtubules. The dissociated tau then aggregates into sequent forms from soluble oligomers to paired helical filaments (PHF), and insoluble neurofibrillary tangles (NFTs). NFTs is a hallmark of AD, while oligomers are found to be the most toxic form of the tau aggregates. Therefore, understanding tau oligomerization with regard of abnormal phosphorylation is important to therapeutic development of AD. In this study, we investigated the impact of phosphorylated Ser293, one of 40 aberrant phosphorylation sites of full‐length tau protein, on monomeric and dimeric structures of tau repeat R2 peptides Method Wild‐type tau repeat R2 (wtR2) was taken from an experimental structure of R2‐microtubule complex (PDB code 6CVN). The phosphorylated Ser293 R2 peptide (pS293R2) was obtained by phosphorylating the wtR2 at Ser293 residue. Extensive replica exchange molecular dynamics simulations using all‐atom force field and explicit solvent were carried out for five systems including two monomers (wtR2 and pS293R2) and three dimers (wtR2+wtR2, wtR2+pS293R2, and pS293R2+ pS293R2). The structures of R2 monomers and dimers sampled by the simulations were characterized and compared. Result For monomeric conformations, the phosphorylation enhances intramolecular interaction, compactness and β content. For dimeric cases, the phosphorylation increases intermolecular interaction, β‐sheet formation, and turn‐coil structural transition. Interestingly, the phosphorylated residue strongly interacts with cations, resulting in a pS293‐cation‐pS293 bridge in pS293R2+ pS293R2 system. Conclusion Our results suggest that abnormal phosphorylation at Ser293 accelerates the oligomerization of R2 peptides, and consequently it may promote tau aggregation. Furthermore, we also found a pS293‐cation‐pS293 bridge formed, thus uncovered the essential role of cation ions in the oligomerization of the phosphorylated R2 repeat. Our findings suggest that phosphorylation at Ser293 should be taken into consideration when screening the inhibitors of tau oligomerization.

The role of specific phosphorylation patterns in the oligomerization of Tau-R4

Synthesis and conformational properties of phosphopeptides related to the human tau protein.

Phosphorylation of Tau R2 Repeat Destabilizes Its Binding to Microtubules: A Molecular Dynamics Simulation Study

Phosphorylation at Ser289 Enhances the Oligomerization of Tau Repeat R2

Abnormal Phosphorylation at Ser293 promotes the Oligomerization of Tau Repeat R2: A Computational Study

Uncovering the Effect of Ps202/pt205/ps208 Triple Phosphorylations on the Conformational Features of the Key Fragment G192-T212 of Tau Protein

Phosphorylation and O-GlcNAcylation of the PHF-1 Epitope of Tau Protein Induce Local Conformational Changes of the C-Terminus and Modulate Tau Self-Assembly Into Fibrillar Aggregates

How Does Hyperphopsphorylation Promote Tau Aggregation and Modulate Filament Structure and Stability?

Phosphoryl group wires stabilize pathological tau fibrils as revealed by multiple quantum spin counting NMR

Single-molecule imaging of Tau reveals how phosphorylation affects its movement and confinement in living cells

The Self-Assembly Ability of the First Microtubule-Binding Repeat from Tau and Its Modulation by Phosphorylation

nP-collabs: Investigating counterion mediated bridges in the multiply phosphorylated tau-R2 repeat

Atomistic Insights into the Inhibitory Mechanism of Tyrosine Phosphorylation Against the Aggregation of Human Tau Fragment PHF6.

Phosphorylation of Tau Protein by CDK2/cyclin A and GSK3β Recombinant Kinases: Analysis of Phosphorylation Patterns by Nuclear Magnetic Resonance Spectroscopy

Aggregation promoting sequences rather than phosphorylation are essential for Tau-mediated toxicity in

n P-Collabs: Investigating Counterion-Mediated Bridges in the Multiply Phosphorylated Tau-R2 Repeat

Identification of Aggregation Mechanism of Acetylated PHF6* and PHF6 Tau Peptides Based on Molecular Dynamics Simulations and Markov State Modeling.

Hiding in plain sight: Complex interaction patterns between Tau and 14-3-3ζ protein variants

Glycation alter the process of Tau phosphorylation to change Tau isoforms aggregation property

O-GlcNAcylation Modulates the Self-Aggregation Ability of the Fourth Microtubule-Binding Repeat of Tau